Cite
HARVARD Citation
Landovitz, R. et al. (2020). Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial. Lancet. 7 (7), pp. e472-e481. [Online].